← Open Payments lookup

CLAUDIA ORTIZ: Open Payments

NPI 1912570391 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,672 in 107 payments from 24 companies in 2025. Trend: 2023 $1,039 · 2024 $1,870 · 2025 $2,672

Food & beverage: $2,672
CompanyPaymentsAmount
Regeneron Healthcare Solutions, Inc.12$369
AstraZeneca Pharmaceuticals LP12$354
Boehringer Ingelheim Pharmaceuticals, Inc.9$338
Lilly USA, LLC6$230
Verona Pharma, Inc.6$174
Amgen Inc.17$166
GlaxoSmithKline, LLC.13$165
Novo Nordisk Inc1$125
Takeda Pharmaceuticals U.S.A., Inc.3$88
United Therapeutics Corporation3$79

Products named: DUPIXENT, TEZSPIRE, Ohtuvayre, OFEV, TRELEGY ELLIPTA, MOUNJARO, AIRSUPRA, Ozempic.

Industry payments across CA — which companies pay providers there.